BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 22227116)

  • 1. Essential features and rational design of CRISPR RNAs that function with the Cas RAMP module complex to cleave RNAs.
    Hale CR; Majumdar S; Elmore J; Pfister N; Compton M; Olson S; Resch AM; Glover CV; Graveley BR; Terns RM; Terns MP
    Mol Cell; 2012 Feb; 45(3):292-302. PubMed ID: 22227116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three CRISPR-Cas immune effector complexes coexist in Pyrococcus furiosus.
    Majumdar S; Zhao P; Pfister NT; Compton M; Olson S; Glover CV; Wells L; Graveley BR; Terns RM; Terns MP
    RNA; 2015 Jun; 21(6):1147-58. PubMed ID: 25904135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RNA- and DNA-targeting CRISPR-Cas immune systems of Pyrococcus furiosus.
    Terns RM; Terns MP
    Biochem Soc Trans; 2013 Dec; 41(6):1416-21. PubMed ID: 24256230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex.
    Hale CR; Zhao P; Olson S; Duff MO; Graveley BR; Wells L; Terns RM; Terns MP
    Cell; 2009 Nov; 139(5):945-56. PubMed ID: 19945378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA targeting by the type I-G and type I-A CRISPR-Cas systems of Pyrococcus furiosus.
    Elmore J; Deighan T; Westpheling J; Terns RM; Terns MP
    Nucleic Acids Res; 2015 Dec; 43(21):10353-63. PubMed ID: 26519471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target RNA capture and cleavage by the Cmr type III-B CRISPR-Cas effector complex.
    Hale CR; Cocozaki A; Li H; Terns RM; Terns MP
    Genes Dev; 2014 Nov; 28(21):2432-43. PubMed ID: 25367038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of an RNA silencing complex of the CRISPR-Cas immune system.
    Spilman M; Cocozaki A; Hale C; Shao Y; Ramia N; Terns R; Terns M; Li H; Stagg S
    Mol Cell; 2013 Oct; 52(1):146-52. PubMed ID: 24119404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog.
    Osawa T; Inanaga H; Sato C; Numata T
    Mol Cell; 2015 May; 58(3):418-30. PubMed ID: 25921071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity.
    Zhang J; Rouillon C; Kerou M; Reeks J; Brugger K; Graham S; Reimann J; Cannone G; Liu H; Albers SV; Naismith JH; Spagnolo L; White MF
    Mol Cell; 2012 Feb; 45(3):303-13. PubMed ID: 22227115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR-Cas system.
    Elmore JR; Sheppard NF; Ramia N; Deighan T; Li H; Terns RM; Terns MP
    Genes Dev; 2016 Feb; 30(4):447-59. PubMed ID: 26848045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CRISPR-associated Csx1 protein of Pyrococcus furiosus is an adenosine-specific endoribonuclease.
    Sheppard NF; Glover CV; Terns RM; Terns MP
    RNA; 2016 Feb; 22(2):216-24. PubMed ID: 26647461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmable plasmid interference by the CRISPR-Cas system in Thermococcus kodakarensis.
    Elmore JR; Yokooji Y; Sato T; Olson S; Glover CV; Graveley BR; Atomi H; Terns RM; Terns MP
    RNA Biol; 2013 May; 10(5):828-40. PubMed ID: 23535213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of Cmr2 suggests a nucleotide cyclase-related enzyme in type III CRISPR-Cas systems.
    Zhu X; Ye K
    FEBS Lett; 2012 Mar; 586(6):939-45. PubMed ID: 22449983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential requirements for the detection and degradation of invaders by the Haloferax volcanii CRISPR/Cas system I-B.
    Maier LK; Lange SJ; Stoll B; Haas KA; Fischer S; Fischer E; Duchardt-Ferner E; Wöhnert J; Backofen R; Marchfelder A
    RNA Biol; 2013 May; 10(5):865-74. PubMed ID: 23594992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallization and preliminary X-ray diffraction analysis of the CRISPR-Cas RNA-silencing Cmr complex.
    Osawa T; Inanaga H; Numata T
    Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):735-40. PubMed ID: 26057804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR RNA-guided DNA cleavage by reconstituted Type I-A immune effector complexes.
    Majumdar S; Terns MP
    Extremophiles; 2019 Jan; 23(1):19-33. PubMed ID: 30284045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hot and crispy: CRISPR-Cas systems in the hyperthermophile Sulfolobus solfataricus.
    Zhang J; White MF
    Biochem Soc Trans; 2013 Dec; 41(6):1422-6. PubMed ID: 24256231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prokaryotic silencing (psi)RNAs in Pyrococcus furiosus.
    Hale C; Kleppe K; Terns RM; Terns MP
    RNA; 2008 Dec; 14(12):2572-9. PubMed ID: 18971321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A complex of Cas proteins 5, 6, and 7 is required for the biogenesis and stability of clustered regularly interspaced short palindromic repeats (crispr)-derived rnas (crrnas) in Haloferax volcanii.
    Brendel J; Stoll B; Lange SJ; Sharma K; Lenz C; Stachler AE; Maier LK; Richter H; Nickel L; Schmitz RA; Randau L; Allers T; Urlaub H; Backofen R; Marchfelder A
    J Biol Chem; 2014 Mar; 289(10):7164-7177. PubMed ID: 24459147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the Cmr2-Cmr3 subcomplex in the CRISPR-Cas RNA silencing effector complex.
    Osawa T; Inanaga H; Numata T
    J Mol Biol; 2013 Oct; 425(20):3811-23. PubMed ID: 23583914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.